Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL

Published:2016-09-10 Issue:42 Volume:7 Page:68833-68841
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sharma Shruti¹,Galanina Natalie²,Guo Ailin¹,Lee Jimmy¹,Kadri Sabah¹³,Van Slambrouck Charles¹,Long Bradley¹,Wang Weige¹,Ming Mei¹,Furtado Larissa V.¹,Segal Jeremy P.¹,Stock Wendy²,Venkataraman Girish¹,Tang Wei-Jen⁴,Lu Pin¹,Wang Yue Lynn¹

Affiliation:

1. Department of Pathology, University of Chicago, Chicago, IL 60637, USA

2. Department of Medicine, University of Chicago, Chicago, IL 60637, USA

3. Center for Research Informatics, University of Chicago, Chicago, IL 60637, USA

4. Ben-May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Solvent-Front Mutations for Kinase Drug Discovery: From Structural Basis to Design Strategies;Journal of Medicinal Chemistry;2024-08-15

2. The Evolving Role of Bruton’s Tyrosine Kinase Inhibitors in B Cell Lymphomas;International Journal of Molecular Sciences;2024-07-09

3. Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia;Cancers;2024-05-28

4. Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed;Cancers;2024-05-25

5. Targeted Therapies in the Treatment of Mantle Cell Lymphoma;Cancers;2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP